ComVest Portfolio Company, Averion International Corp., Acquires Hesperion AG
West Palm Beach, Fl., November 1, 2007 – ComVest’s portfolio company, Averion International Corp. (OTC:AVRO) (“Averion”), today announced that it has acquired Hesperion AG (“Hesperion”), a Swiss-based, international, full-service, clinical research organization (CRO), from its parent company, Cerep SA. The €25.0 million (approximately $36.2 million) acquisition purchase price included an upfront cash payment of €20.0